Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: A meta-analytic approach

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Estimates of penetrance (or risk) of breast cancer among BRCA mutation carriers in published studies are heterogeneous, prohibiting direct combined estimates. Estimates of prevalence of BRCA mutations are more homogeneous and could allow combined estimates of prevalence. We propose a combined estimator of penetrance from combined estimates of the prevalence of BRCA mutations in women with and without breast cancer and from the probability of breast cancer by using Bayes' Theorem. The relative risk of having breast cancer with positive family history and the prevalence of positive family history contribute to the combined estimate of penetrance if family history is present. The combined estimate incorporates variation in estimates from different resources. The method is illustrated by using data from Ashkenazi Jewish women unselected for family history and for those with family history. Risks of breast cancer conferred by BRCA1 and BRCA2 mutations are estimated to be 8.39 per cent (6.56, 10.68 per cent) and 2.66 per cent (1.85, 3.82 per cent) by 40 years old, and 47.45 per cent (37.39, 57.72 per cent) and 31.85 per cent (23.72, 41.26 per cent) by 75 years old, respectively. For those with family history, risks of breast cancer conferred by BRCA mutations appear to be higher.

Original languageEnglish (US)
Pages (from-to)1775-1787
Number of pages13
JournalStatistics in Medicine
Volume26
Issue number8
DOIs
StatePublished - Apr 15 2007

Fingerprint

Breast Cancer
Mutation
Breast Neoplasms
Penetrance
Estimate
Bayes Theorem
Bayes' Formula
Relative Risk
History
Family
Estimator
Resources

Keywords

  • BRCA mutations
  • Breast cancer risk
  • Family history
  • Meta-analysis
  • Penetrance
  • Prevalence

ASJC Scopus subject areas

  • Epidemiology

Cite this

Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations : A meta-analytic approach. / Fu, Rongwei (Rochelle); Harris, Emily L.; Helfand, Mark; Nelson, Heidi.

In: Statistics in Medicine, Vol. 26, No. 8, 15.04.2007, p. 1775-1787.

Research output: Contribution to journalArticle

@article{23e8a8c73c964c61981bb3d5c85958d4,
title = "Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: A meta-analytic approach",
abstract = "Estimates of penetrance (or risk) of breast cancer among BRCA mutation carriers in published studies are heterogeneous, prohibiting direct combined estimates. Estimates of prevalence of BRCA mutations are more homogeneous and could allow combined estimates of prevalence. We propose a combined estimator of penetrance from combined estimates of the prevalence of BRCA mutations in women with and without breast cancer and from the probability of breast cancer by using Bayes' Theorem. The relative risk of having breast cancer with positive family history and the prevalence of positive family history contribute to the combined estimate of penetrance if family history is present. The combined estimate incorporates variation in estimates from different resources. The method is illustrated by using data from Ashkenazi Jewish women unselected for family history and for those with family history. Risks of breast cancer conferred by BRCA1 and BRCA2 mutations are estimated to be 8.39 per cent (6.56, 10.68 per cent) and 2.66 per cent (1.85, 3.82 per cent) by 40 years old, and 47.45 per cent (37.39, 57.72 per cent) and 31.85 per cent (23.72, 41.26 per cent) by 75 years old, respectively. For those with family history, risks of breast cancer conferred by BRCA mutations appear to be higher.",
keywords = "BRCA mutations, Breast cancer risk, Family history, Meta-analysis, Penetrance, Prevalence",
author = "Fu, {Rongwei (Rochelle)} and Harris, {Emily L.} and Mark Helfand and Heidi Nelson",
year = "2007",
month = "4",
day = "15",
doi = "10.1002/sim.2811",
language = "English (US)",
volume = "26",
pages = "1775--1787",
journal = "Statistics in Medicine",
issn = "0277-6715",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations

T2 - A meta-analytic approach

AU - Fu, Rongwei (Rochelle)

AU - Harris, Emily L.

AU - Helfand, Mark

AU - Nelson, Heidi

PY - 2007/4/15

Y1 - 2007/4/15

N2 - Estimates of penetrance (or risk) of breast cancer among BRCA mutation carriers in published studies are heterogeneous, prohibiting direct combined estimates. Estimates of prevalence of BRCA mutations are more homogeneous and could allow combined estimates of prevalence. We propose a combined estimator of penetrance from combined estimates of the prevalence of BRCA mutations in women with and without breast cancer and from the probability of breast cancer by using Bayes' Theorem. The relative risk of having breast cancer with positive family history and the prevalence of positive family history contribute to the combined estimate of penetrance if family history is present. The combined estimate incorporates variation in estimates from different resources. The method is illustrated by using data from Ashkenazi Jewish women unselected for family history and for those with family history. Risks of breast cancer conferred by BRCA1 and BRCA2 mutations are estimated to be 8.39 per cent (6.56, 10.68 per cent) and 2.66 per cent (1.85, 3.82 per cent) by 40 years old, and 47.45 per cent (37.39, 57.72 per cent) and 31.85 per cent (23.72, 41.26 per cent) by 75 years old, respectively. For those with family history, risks of breast cancer conferred by BRCA mutations appear to be higher.

AB - Estimates of penetrance (or risk) of breast cancer among BRCA mutation carriers in published studies are heterogeneous, prohibiting direct combined estimates. Estimates of prevalence of BRCA mutations are more homogeneous and could allow combined estimates of prevalence. We propose a combined estimator of penetrance from combined estimates of the prevalence of BRCA mutations in women with and without breast cancer and from the probability of breast cancer by using Bayes' Theorem. The relative risk of having breast cancer with positive family history and the prevalence of positive family history contribute to the combined estimate of penetrance if family history is present. The combined estimate incorporates variation in estimates from different resources. The method is illustrated by using data from Ashkenazi Jewish women unselected for family history and for those with family history. Risks of breast cancer conferred by BRCA1 and BRCA2 mutations are estimated to be 8.39 per cent (6.56, 10.68 per cent) and 2.66 per cent (1.85, 3.82 per cent) by 40 years old, and 47.45 per cent (37.39, 57.72 per cent) and 31.85 per cent (23.72, 41.26 per cent) by 75 years old, respectively. For those with family history, risks of breast cancer conferred by BRCA mutations appear to be higher.

KW - BRCA mutations

KW - Breast cancer risk

KW - Family history

KW - Meta-analysis

KW - Penetrance

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=33947405732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947405732&partnerID=8YFLogxK

U2 - 10.1002/sim.2811

DO - 10.1002/sim.2811

M3 - Article

C2 - 17243094

AN - SCOPUS:33947405732

VL - 26

SP - 1775

EP - 1787

JO - Statistics in Medicine

JF - Statistics in Medicine

SN - 0277-6715

IS - 8

ER -